BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19878772)

  • 21. Non-secreted clusterin isoforms are translated in rare amounts from distinct human mRNA variants and do not affect Bax-mediated apoptosis or the NF-κB signaling pathway.
    Prochnow H; Gollan R; Rohne P; Hassemer M; Koch-Brandt C; Baiersdörfer M
    PLoS One; 2013; 8(9):e75303. PubMed ID: 24073260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clusterin/Apolipoprotein J up-regulation after zinc exposure, replicative senescence or differentiation of human haematopoietic cells.
    Trougakos IP; Pawelec G; Tzavelas C; Ntouroupi T; Gonos ES
    Biogerontology; 2006; 7(5-6):375-82. PubMed ID: 16955214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular chaperone apolipoprotein J/clusterin as a sensor of oxidative stress: implications in therapeutic approaches - a mini-review.
    Trougakos IP
    Gerontology; 2013; 59(6):514-23. PubMed ID: 23689375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of clusterin (CLU) in malignant transformation and drug resistance in breast carcinomas.
    Redondo M; Tellez T; Roldan MJ
    Adv Cancer Res; 2009; 105():21-43. PubMed ID: 19879421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clusterin over-expression modulates proapoptotic and antiproliferative effects of 1,25(OH)2D3 in prostate cancer cells in vitro.
    Shannan B; Seifert M; Boothman DA; Tilgen W; Reichrath J
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):721-5. PubMed ID: 17224269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms of the antimetastatic activity of nuclear clusterin in prostate cancer cells.
    Moretti RM; Mai S; Montagnani Marelli M; Rizzi F; Bettuzzi S; Limonta P
    Int J Oncol; 2011 Jul; 39(1):225-34. PubMed ID: 21573492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chapter 5: Nuclear CLU (nCLU) and the fate of the cell.
    Bettuzzi S; Rizzi F
    Adv Cancer Res; 2009; 104():59-88. PubMed ID: 19878773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control.
    Shannan B; Seifert M; Boothman DA; Tilgen W; Reichrath J
    J Mol Histol; 2006 Sep; 37(5-7):183-8. PubMed ID: 17048076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced expression levels of the senescence biomarker clusterin/apolipoprotein j in lymphocytes from healthy centenarians.
    Trougakos IP; Petropoulou C; Franceschi C; Gonos ES
    Ann N Y Acad Sci; 2006 May; 1067():294-300. PubMed ID: 16804001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional analysis of clusterin/apolipoprotein J in cellular death induced by severe genotoxic stress.
    Trougakos IP; Gonos ES
    Ann N Y Acad Sci; 2004 Jun; 1019():206-10. PubMed ID: 15247015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer.
    Shannan B; Seifert M; Leskov K; Willis J; Boothman D; Tilgen W; Reichrath J
    Cell Death Differ; 2006 Jan; 13(1):12-9. PubMed ID: 16179938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer.
    Li N; Zoubeidi A; Beraldi E; Gleave ME
    Oncogene; 2013 Apr; 32(15):1933-42. PubMed ID: 22689054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of clusterin/apoJ expression by histone deacetylase inhibitors in neural cells.
    Nuutinen T; Suuronen T; Kyrylenko S; Huuskonen J; Salminen A
    Neurochem Int; 2005 Dec; 47(8):528-38. PubMed ID: 16157419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells1.
    Scaltriti M; Santamaria A; Paciucci R; Bettuzzi S
    Cancer Res; 2004 Sep; 64(17):6174-82. PubMed ID: 15342402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bax gene expression alters Ca(2+) signal transduction without affecting apoptosis in an epithelial cell line.
    Aiba-Masago S; Liu Xb XB; Masago R; Vela-Roch N; Jimenez F; Lau CM; Frohlich VC; Talal N; Dang H
    Oncogene; 2002 Apr; 21(17):2762-7. PubMed ID: 11965549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exon-skipping strategy by ratio modulation between cytoprotective versus pro-apoptotic clusterin forms increased sensitivity of LNCaP to cell death.
    Essabbani A; Garcia L; Zonetti MJ; Fisco T; Pucci S; Chiocchia G
    PLoS One; 2013; 8(2):e54920. PubMed ID: 23418433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clusterin expression during fetal and postnatal CNS development in mouse.
    Charnay Y; Imhof A; Vallet PG; Hakkoum D; Lathuiliere A; Poku N; Aronow B; Kovari E; Bouras C; Giannakopoulos P
    Neuroscience; 2008 Aug; 155(3):714-24. PubMed ID: 18620027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel nucleolar localization of clusterin and its associated functions in human oral cancers: An in vitro and in silico analysis.
    Kadam R; Harish M; Dalvi K; Teni T
    Cell Biochem Funct; 2021 Apr; 39(3):380-391. PubMed ID: 33155695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clusterin is a short half-life, poly-ubiquitinated protein, which controls the fate of prostate cancer cells.
    Rizzi F; Caccamo AE; Belloni L; Bettuzzi S
    J Cell Physiol; 2009 May; 219(2):314-23. PubMed ID: 19137541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CLU-files: disentanglement of a mystery.
    Rohne P; Prochnow H; Koch-Brandt C
    Biomol Concepts; 2016 Feb; 7(1):1-15. PubMed ID: 26673020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.